全球微创手术市场规模（依手术类型、产品类型、应用、区域范围和预测）

微创手术（MIS）市场规模及预测

2024 年微创手术市场规模价值 224 亿美元，预计到 2032 年将达到 355 亿美元，2026 年至 2032 年的复合年增长率为 10.5%。

微创手术 (MIS) 是一种旨在达到与传统开放性手术相同效果，但对身体创伤较小的手术技术。此方法采用小切口、专用设备以及腹腔镜和内视镜等先进技术，使外科医生无需进行大切口即可观察和操作内部组织。 MIS 的主要优点是术后不适感更少、住院时间更短、癒合时间更快、疤痕更少。

微创手术应用于各科室，包括一般外科、整形外科、妇科、泌尿系统和循环系统。微创手术（MIS）的常见手术包括腹腔镜胆囊切除术（胆囊切除术）、关节镜手术、腹腔镜子宫切除术和内视镜鼻窦手术。随着手术器械和影像技术的不断发展，微创手术的应用范围不断扩大，能够进行越来越复杂、精细的手术。

随着技术的快速进步以及对以患者为中心的医疗护理的日益重视，微创手术 (MIS) 的未来预计将发生变革。其中最显着的进步之一是将机器人技术和人工智慧 (AI) 融入外科手术中。机器人辅助手术正变得越来越普遍，为外科医生提供了更高的精准度、灵活性和控制力，而这些对于透过小切口完成高难度手术至关重要。

全球微创手术市场动态

影响全球微创手术市场的关键市场动态是：

关键市场驱动因素

患者获益和疗效：采用微创手术 (MIS) 的主要原因之一是，与开放性手术相比，MIS 术后疼痛更少、感染疾病风险更低、住院时间更短、恢復更快。这些优势有助于提高患者满意度和整体治疗效果。腹腔镜胆囊切除术（胆囊切除术）和微创心血管手术等手术对患者周围组织的损伤较小，使他们能够更快康復并恢復正常活动。

技术进步：医疗技术的快速发展极大地促进了微创手术（MIS）的发展。高解析度摄影机、微型手术器械、机器人辅助手术系统（例如达文西手术系统）以及先进的影像技术（例如腹腔镜超音波和术中核磁共振成像）使外科医生能够透过小切口以更高的精度和控制力执行复杂的手术。

降低医疗成本：微创手术已证明具有为医疗系统和患者节省成本的潜力。儘管微创手术技术相关的初始资本成本可能较高，但最终的成本效益体现在缩短住院时间、减少手术併发症、减少后续观察以及加快復原时间。从长远来看，这些因素有助于降低医疗成本并提高资源利用率。

主要挑战

技术专长和训练要求：微创手术 (MIS) 的关键问题之一是获得必要技能和能力所需的学习曲线较高。外科医生需要经过特殊培训，具备使用内视镜和机器人器械透过小切口进行手术的技能。 MIS 所需的技能和手眼协调能力通常与传统开放性手术不同。

设备和器械成本：专用设备和器械的高昂成本限制了微创手术的普及。微创手术中使用的内视镜、腹腔镜器械、机器人系统和其他创新技术的购买、维护和升级成本高昂。医疗保健机构必须付出巨大努力才能获得这些技术，这可能会造成财政资源紧张。

併发症风险与学习曲线：儘管微创手术 (MIS) 比传统开放性手术併发症更少、恢復更快，但引入 MIS 并非没有风险。 MIS 手术的学习曲线可能会导致术中问题增多，例如意外的器官损伤、出血以及转为开放性手术。初入 MIS 领域的外科医生可能会面临难以透过小切口正确评估解剖结构以及处理术中意外观察。

主要趋势：

适应症不断扩展：MIS 最初仅限于阑尾切除术和胆囊切除术等手术，如今已扩展到广泛的外科专科。微创心血管手术(MICS)、微创脊椎手术和机器人辅助妇科手术等复杂手术已成为标准做法。针对特定解剖部位的专用设备和手术的发展，已将 MIS 的效用扩展到更广泛的医疗状况。

改善患者预后：改善患者预后是微创手术 (MIS) 的标誌，并持续推动其应用。对周围组织的创伤更少、术后疼痛更少、恢復时间更快，所有这些都有助于缩短住院时间并降低医疗成本。与开放性手术相比，接受 MIS 的患者疤痕较少，伤口感染疾病风险较低。

培训与教育随着微创手术方法的不断发展，培训与教育已成为关注的重点。外科医师需要接受专门培训，才能掌握微创手术并熟练地运用技术创新。基于模拟的训练计画和虚拟实境 (VR) 模拟器正日益被广泛使用，让外科医生在对患者实施手术前，在受控环境中获得实践经验。

目录

第一章 引言

• 市场定义
• 市场区隔
• 调查方法

第二章执行摘要

• 主要发现
• 市场概览
• 市集亮点

第三章市场概述

• 市场规模和成长潜力
• 市场趋势
• 市场驱动因素
• 市场限制
• 市场机会
• 波特五力分析

4. 微创手术（MIS）市场（依手术类型）

• 腹腔镜手术
• 机器人手术
• 内视镜手术
• 胸腔镜手术

第五章：微创手术（MIS）市场（依产品类型）

• 手术器械
• 机器人系统
• 视觉化系统
• 配件和耗材

第六章 微创手术（MIS）市场：依应用

• 胃肠外科
• 心臟外科手术
• 整形外科
• 妇科手术

第七章区域分析

• 北美洲
• 美国
• 加拿大
• 墨西哥
• 欧洲
• 英国
• 德国
• 法国
• 义大利
• 亚太地区
• 中国
• 日本
• 印度
• 澳洲
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中东和非洲
• 南非
• 沙乌地阿拉伯
• 阿拉伯聯合大公国

第八章市场动态

• 市场驱动因素
• 市场限制
• 市场机会
• COVID-19 市场影响

第九章 竞争态势

• 主要企业
• 市场占有率分析

第十章 公司简介

• Medtronic plc（Ireland）
• Johnson & Johnson（US）
• Stryker Corporation（US）
• Abbott Laboratories（US）
• Boston Scientific Corporation（US）
• Siemens Healthineers AG（Germany）
• Philips（Netherlands）
• GE Healthcare（US）
• Smith & Nephew plc（UK）
• Zimmer Biomet Holdings, Inc.（US）
• Olympus Corporation（Japan）
• Intuitive Surgical Inc.（US）（Focuses on robotic-assisted surgery）
• CONMED Corporation（US）
• B. Braun Melsungen AG（Germany）

第十一章 市场展望与机会

• 新兴技术
• 未来市场趋势
• 投资机会

第十二章 附录

• 简称列表
• 来源和参考文献

Minimally Invasive Surgery (MIS) Market Size And Forecast

Minimally Invasive Surgery Market size was valued at USD 22.4 Billion in 2024 and is projected to reach USD 35.5 Billion by 2032, growing at a CAGR of 10.5% from 2026 to 2032.

Minimally invasive surgery (MIS) is a surgical method that tries to produce the same results as traditional open surgery but causing much less stress to the body. This method employs small incisions, specialized devices, and advanced technology such as laparoscopes and endoscopes allowing surgeons to observe and operate on interior tissues without the need for big incisions. The primary benefits of MIS are decreased postoperative discomfort, shorter hospital stays, faster healing times, and less scarring.

This surgery has numerous applications in a variety of medical specialties including general surgery, orthopedics, gynecology, urology, and cardiology. Common treatments performed with MIS techniques include laparoscopic cholecystectomy (gallbladder removal), arthroscopic joint surgeries, laparoscopic hysterectomy, and endoscopic sinus surgery. Continuous developments in surgical equipment and imaging technologies have broadened the possibilities for MIS allowing for increasingly intricate and delicate procedures.

The future of minimally invasive surgery (MIS) promises to be transformative because of rapid technological improvements and an increasing emphasis on patient-centered care. One of the most notable advancements is the incorporation of robotics and artificial intelligence (AI) into surgical procedures. Robotic-assisted operations are becoming increasingly common providing surgeons with more precision, dexterity, and control all of which are necessary for completing difficult procedures through small incisions.

Global Minimally Invasive Surgery Market Dynamics

The key market dynamics that are shaping the global minimally invasive surgery market include:

Key Market Drivers:

Patient Benefits and Outcomes: One of the key reasons for using MIS is that it provides patients with less postoperative pain, a lower risk of infection, shorter hospital stays, and faster recovery times than open operations. These benefits help to increase patient satisfaction and overall outcomes. Patients undergo less trauma to surrounding tissues during treatments such as laparoscopic cholecystectomy (gallbladder removal) or minimally invasive cardiac surgeries resulting in faster recovery and return to normal activities.

Technological Advancements: Rapid improvements in medical technology have contributed significantly to the growth of MIS. High-definition cameras, miniature surgical instruments, robotic-assisted surgery systems (such as the da Vinci Surgical System), and advanced imaging techniques (such as laparoscopic ultrasound and intraoperative MRI) have allowed surgeons to perform complex procedures more precisely and controllably through small incisions.

Reduced Healthcare Costs: Minimally invasive surgery has shown potential cost reductions for healthcare systems and patients alike. While the initial equipment expenses connected with MIS technology can be high, the eventual cost-effectiveness is demonstrated by shorter hospital stays, less surgical complications, fewer follow-up visits, and faster healing durations. In the long run, these variables contribute to lower healthcare costs and better resource utilization.

Key Challenge:

Technical Expertise and Training Requirements: One of the key problems of MIS is the high learning curve required to master the requisite techniques and abilities. Surgeons need specific training and skill to maneuver through smaller incisions with endoscopic equipment or robotic devices. Skill and hand-eye coordination in MIS are frequently different from those necessary in regular open surgery.

Equipment and Instrumentation Costs: The high cost of specialist equipment and instrumentation limits the deployment of MIS. Endoscopic cameras, laparoscopic equipment, robotic systems, and other technological breakthroughs utilized in MIS are costly to acquire, maintain, and upgrade. Hospitals and healthcare facilities must make large efforts to obtain these technology which might strain financial resources.

Complication Risk and Learning Curve Impact: Although MIS has lower complications and faster recovery periods than traditional open surgery, the move is not without dangers. The learning curve associated with implementing MIS procedures might lead to an increase in intraoperative problems such as unintentional organ injury, hemorrhage, or conversion to open surgery. Surgeons beginning their MIS careers may face difficulties in appropriately assessing anatomy and managing unexpected intraoperative findings through small incisions.

Key Trends:

Indication Expansion: Originally limited to operations such as appendectomies and cholecystectomies, MIS has now grown to include a wide range of surgical specialties. Complex treatments such as minimally invasive heart surgery (MICS), minimally invasive spine surgery, and robotic-assisted gynecological surgeries are already standard practice. The development of specialized devices and techniques targeted to distinct anatomical sites has increased the usefulness of MIS to a wide range of medical disorders.

Improved Patient Outcomes: Improved patient outcomes are a defining feature of MIS and continue to drive adoption. Reduced trauma to surrounding tissues, less postoperative pain, and faster recovery times all contribute to shorter hospital stays and cheaper healthcare expenditures. Compared to open operations, patients who undergo MIS frequently have less scarring and a lower risk of wound infections.

Training and Education: As MIS approaches advance, training and education have become major focal points. Surgeons require specific training to master minimally invasive techniques and skillfully manage technological innovations. Simulation-based training programs and virtual reality (VR) simulators are increasingly being used to give surgeons hands-on experience in a controlled environment prior to performing procedures on patients.

Global Minimally Invasive Surgery Market Regional Analysis

North America

North America leads the global minimally invasive surgeries (MIS) market which is seeing strong growth due to a number of major drivers. One critical issue is the growing frequency of chronic diseases throughout the region which range from cardiovascular disorders to orthopedic ailments and malignancies. As chronic illnesses become increasingly common, there is a greater desire for improved medical solutions that provide less invasive treatment choices. Minimally invasive operations which have smaller incisions, shorter recovery times, and a lower risk of problems than standard open surgeries are growing popular among both patients and healthcare practitioners.

The extensive use of minimally invasive operations in North America can be traced to a gradual shift in medical practice and patient preferences. Healthcare systems in the region are increasingly emphasizing the benefits of MIS which include shorter hospital stays, faster recovery times, and better cosmetic outcomes. These benefits not only improve patient satisfaction but also lead to cost savings in the healthcare system.

Furthermore, advances in surgical instruments, imaging technology, and robotics have greatly increased the scope and precision of MIS treatments making them appropriate for a wider range of medical disorders.

Europe

The European market for minimally invasive operations is expanding rapidly owing to considerable government backing aimed at promoting wider use throughout the area. European governments are actively encouraging minimally invasive procedures because of its multiple advantages such as faster recovery times, fewer risk of problems, and shorter hospital stays. These methods which use advanced technologies and techniques to perform surgeries through small incisions rather than traditional open surgery are becoming increasingly popular among healthcare providers and patients alike.

European government's assistance includes measures to improve healthcare professional training in minimally invasive treatments, money for medical device research and development, and incentives for hospitals to invest in cutting-edge surgical equipment. These efforts are intended to improve healthcare outcomes, optimize resource use within healthcare systems, and lower overall healthcare expenditures. As a result, the European market for minimally invasive operations is expected to grow further with advances in surgical instruments, imaging technology, and surgical robotics driving additional progress.

Global Minimally Invasive Surgery Market: Segmentation Analysis

The Global Minimally Invasive Surgery Market is segmented based on Type of Surgery, Applications, Product Type, and Geography.

Minimally Invasive Surgery Market, By Type of Surgery

• Surgical Instruments
• Robotics Systems
• Visualization Systems
• Accessories and Consumables

Based on Type of Surgery, the Global Minimally Invasive Surgery Market is bifurcated into Surgical Instruments, Robotics Systems, Visualization Systems, Accessories and Consumables. Robotic surgery is emerging as the dominant type within the minimally invasive surgery (MIS) market. Robotic systems offer surgeons enhanced precision, dexterity, and 3D visualization capabilities which are crucial for performing complex procedures with greater accuracy compared to traditional methods. These systems enable minimally invasive surgeries across various specialties including urology, gynecology, and general surgery, thereby expanding their applicability and adoption. Furthermore, robotic surgery platforms continue to evolve with advancements in artificial intelligence and machine learning promising even greater surgical outcomes and efficiency.

Minimally Invasive Surgery Market, By Application

• Gastrointestinal Surgery
• Cardiothoracic Surgery
• Orthopedic Surgery
• Gynecological Surgery

Based on Application, the Global Minimally Invasive Surgery Market is bifurcated into Gastrointestinal Surgery, Cardiothoracic Surgery, Orthopedic Surgery, and Gynecological Surgery. Among the listed applications, minimally invasive surgery (MIS) in orthopedic surgery stands out as particularly dominant. This dominance can be attributed to several factors. Advancements in arthroscopic techniques have revolutionized the treatment of orthopedic conditions like knee injuries, shoulder problems, and hip disorders. These procedures offer patients reduced recovery times, minimal scarring, and lower risks of infection compared to traditional open surgeries. Moreover, the aging population and increasing sports-related injuries have fueled the demand for orthopedic interventions that offer quicker rehabilitation and less post-operative pain. Overall, the combination of clinical effectiveness, patient preference for quicker recovery, and ongoing technological innovation positions orthopedic MIS as the dominant application within the broader MIS market landscape.

Minimally Invasive Surgery Market, By Product Type

• Surgical Instruments
• Robotics Systems
• Visualization Systems
• Accessories and Consumables

Based on Product Type, the Global Minimally Invasive Surgery Market is bifurcated into Surgical Instruments, Robotics Systems, Visualization Systems, Accessories and Consumables. In the minimally invasive surgery (MIS) market, surgical instruments dominate due to their essential role in performing precise and controlled procedures. These instruments including laparoscopic graspers, scissors, dissectors, and trocars are fundamental for manipulating tissues and organs through small incisions minimizing trauma and promoting quicker recovery times for patients. Surgical instruments are widely used across various specialties such as general surgery, gynecology, urology, and orthopedics contributing significantly to the overall adoption of minimally invasive techniques. Their versatility coupled with advancements in design and materials continually enhances surgical outcomes and patient safety.

Minimally Invasive Surgery Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

Based on Geography, the Global Minimally Invasive Surgery Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. Among the regions mentioned, North America stands out as dominant in the minimally invasive surgery (MIS) market. The United States leads due to advanced healthcare infrastructure, high healthcare expenditure, and a strong focus on technological innovation. The market in the US benefits from extensive research and development activities, favorable reimbursement policies, and a large patient pool opting for minimally invasive procedures. Overall, North America's dominance in the MIS market is bolstered by its robust healthcare system, technological advancements, and proactive government support.

Key Players

The "Global Minimally Invasive Surgery Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Medtronic plc, Johnson & Johnson, Stryker Corporation, Abbott Laboratories, Boston Scientific Corporation, Siemens Healthineers AG, Philips, GE Healthcare, Smith & Nephew plc, Zimmer Biomet Holdings, Inc., Olympus Corporation, Intuitive Surgical Inc., CONMED Corporation, and B. Braun Melsungen AG.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Global Minimally Invasive Surgery Market Key Developments

• In June 2022, Boston Scientific agreed to buy a controlling stake in M.I.Tech, a manufacturer and distributor of non-vascular metal stents used in endoscopic and urologic operations, from South Korea's Synergy Innovation. Boston Scientific offered about KRW 14,500 (about USD 11) per M.I.Tech share, for a total price of KRW 291.2, or around USD 230 million.
• In January 2024, PENTAX Medical received CE certification for its PENTAX Medical INSPIRA, a new premium video processor, and the i20c video endoscope series. The new video processor retains compatibility with PENTAX Medical's most recent endoscope models while also setting new standards with the new i20c video endoscope generation.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Minimally Invasive Surgery (MIS) Market , By Type of Surgery

• Laparoscopic Surgery
• Robotic Surgery
• Endoscopic Surgery
• Thoracoscopic Surgery

5. Minimally Invasive Surgery (MIS) Market, By Product Type

• Surgical Instruments
• Robotics Systems
• Visualization Systems
• Accessories and Consumables

6. Minimally Invasive Surgery (MIS) Market, By Application

• Gastrointestinal Surgery
• Cardiothoracic Surgery
• Orthopedic Surgery
• Gynecological Surgery

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Medtronic plc (Ireland)
• Johnson & Johnson (US)
• Stryker Corporation (US)
• Abbott Laboratories (US)
• Boston Scientific Corporation (US)
• Siemens Healthineers AG (Germany)
• Philips (Netherlands)
• GE Healthcare (US)
• Smith & Nephew plc (UK)
• Zimmer Biomet Holdings, Inc. (US)
• Olympus Corporation (Japan)
• Intuitive Surgical Inc. (US) (Focuses on robotic-assisted surgery)
• CONMED Corporation (US)
• B. Braun Melsungen AG (Germany)

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References